INCOME STATEMENT
AstraZeneca Pharma India Ltd.
BSE
Jul 25
8832.65
-188.55 ( -2.09%)
Volume
468
Prev. Close
9021.20
Open Price
8988.85
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jul 25
8867.50
-157.00 ( -1.74%)
Volume
10938
Prev. Close
9024.50
Open Price
9028.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE203A01020
|
Market Cap. ( ₹ in Cr. )
|
22168.75
|
P/BV
|
32.63
|
Book Value ( ₹ )
|
271.74
|
BSE Code
|
506820
|
52 Week High/Low ( ₹ )
|
10691/6220
|
FV/ML
|
2/1
|
P/E(X)
|
191.54
|
NSE Code
|
ASTRAZENEQ
|
Book Closure
|
18/07/2025
|
EPS ( ₹ )
|
46.30
|
Div Yield (%)
|
0.36
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 1713.29 | 1295.53 | 1002.97 | 805.60 | 813.56 |
Other Operating Revenues | 3.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Operating Revenues | 1716.29 | 1295.53 | 1002.97 | 805.60 | 813.56 |
| | | | | |
Other Income | 40.63 | 34.80 | 26.10 | 14.76 | 12.84 |
Total Revenue | 1756.92 | 1330.33 | 1029.07 | 820.36 | 826.40 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 287.13 | 129.02 | 84.38 | 89.61 | 97.26 |
Purchase Of Stock-In Trade | 1008.82 | 499.31 | 324.46 | 207.88 | 194.74 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -332.94 | -33.77 | -48.86 | 14.47 | 2.95 |
Employee Benefit Expenses | 257.44 | 241.45 | 259.10 | 230.21 | 219.54 |
Finance Costs | 1.46 | 1.20 | 0.63 | 0.95 | 1.09 |
Depreciation And Amortisation Expenses | 39.99 | 14.94 | 16.26 | 16.95 | 20.13 |
Other Expenses | 241.87 | 275.07 | 218.77 | 177.25 | 163.60 |
Total Expenses | 1503.77 | 1127.22 | 854.74 | 737.32 | 699.31 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 253.15 | 203.11 | 174.33 | 83.04 | 127.09 |
| | | | | |
Exceptional Items | -96.79 | 16.43 | -40.23 | 0.00 | 0.00 |
Profit/Loss Before Tax | 156.36 | 219.54 | 134.10 | 83.04 | 127.09 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 60.10 | 53.55 | 38.30 | 22.63 | 34.83 |
Deferred Tax | -19.92 | -0.90 | -3.49 | -1.19 | -1.04 |
Tax For Earlier Years | 0.44 | 5.38 | 0.00 | 0.00 | 0.00 |
Total Tax Expenses | 40.62 | 58.03 | 34.81 | 21.44 | 33.79 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 115.74 | 161.51 | 99.29 | 61.60 | 93.30 |
| | | | | |
Profit/Loss From Continuing Operations | 115.74 | 161.51 | 99.29 | 61.60 | 93.30 |
| | | | | |
Profit/Loss For The Period | 115.74 | 161.51 | 99.29 | 61.60 | 93.30 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 46.30 | 64.60 | 39.70 | 24.60 | 37.30 |
Diluted EPS (Rs.) | 46.30 | 64.60 | 39.70 | 24.60 | 37.30 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 60.00 | 40.00 | 20.00 | 5.00 | 5.00 |
Equity Dividend Rate (%) | 1600.00 | 1200.00 | 800.00 | 500.00 | 100.00 |